FDA review: No increased risk of heart problems with Nexium, Prilosec

12/10/2007 | CNNMoney

The FDA said a review of additional studies shows AstraZeneca's Nexium and Prilosec are "not likely to be associated with an increased risk of heart problems" and should continue to be prescribed and used for gastroesophageal reflux disease.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA
Assistant General Counsel, Regulatorya
Cardinal Health
Waukegan, IL
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA